EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail
Read full article: EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company GrailThe European Union is ordering U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal without approval of regulators.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/MP7MFB2SERGNJHB6T5WKUELGLY.jpg)
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65):fill(FFF)/cloudfront-us-east-1.images.arcpublishing.com/gmg/Y6QP3LHAVFECBKGIAU2GGXCLYI.jpg)
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/RSMCE2J2SRDSLOADAFT5MBIUNI.jpg)
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/VSDPOBN7F5B5DKVAIV7FJ5HMRY.jpg)
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/2CIB5N2UNJEF5IKSYFQ5GSWILM.jpg)
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/cloudfront-us-east-1.images.arcpublishing.com/gmg/H7AQAA4HQZCSXMIDS7KUJ5DEDI.jpg)